• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Influenza Virus Vaccine for the 2001-2002 Season

2001/2002 Season Lot Release Status (as of December 18, 2001)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers.

For information on flu vaccine distribution schedules, please contact the manufacturers directly.

Manufacturer Total Number of Lots Released by FDA
Fluzone
Aventis-Pasteur Inc.
(Connaught Laboratories, Inc.)
Discovery Drive
Swiftwater, PA 18370-0187
(800) 720-8972
fax: 888-889-7129
77
Fluvirin
Evans Vaccines Limited
585 Science Drive
Madison, WI 53711
26
Flushield
Wyeth Laboratories, Inc.
Wasp and Biddle Streets
P.O. Box 354
Marietta, PA 17547-0354
(800) Flushield
(800) 358-7443
58

The trivalent influenza vaccine prepared for the 2001-2002 season will include A/Moscow/10/99-like (H3N2), A/New Caledonia/20/99-like (H1N1), and B/Sichuan/379/99-like antigens. For the A/Moscow/10/99-like (H3N2) antigen, U.S. manufacturers will use the antigenically equivalent A/Panama/2007/99 (H3N2) virus. For the B/Sichuan/379/99-like antigen, they will use one of the antigenically equivalent viruses B/Johannesburg/05/99, B/Victoria/504/2000, or B/Guangdong/120/2000. These viruses will be used in manufacturing because of their growth properties and because they are representative of currently circulating influenza A (H3N2) and B viruses.